4//SEC Filing
FUCHS JAMES J 4
Accession 0000884905-11-000005
CIK 0000884905other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 7:29 PM ET
Size
24.0 KB
Accession
0000884905-11-000005
Insider Transaction Report
Form 4
FUCHS JAMES J
Senior Vice President
Transactions
- Exercise/Conversion
Common Stock
2011-01-28$53.98/sh+62,600$3,379,148→ 67,086 total - Sale
Common Stock
2011-01-28$91.10/sh−62,600$5,702,860→ 4,486 total - Exercise/Conversion
Common Stock
2011-01-31$61.47/sh+69,400$4,266,018→ 73,886 total - Sale
Common Stock
2011-01-31$92.42/sh−69,400$6,413,948→ 4,486 total - Exercise/Conversion
Stock Option (right to buy)
2011-01-28−62,600→ 0 totalExercise: $53.98From: 2007-02-28Exp: 2016-02-28→ Common Stock (62,600 underlying) - Exercise/Conversion
Stock Option (right to buy)
2011-01-31−69,400→ 0 totalExercise: $61.47From: 2008-02-27Exp: 2017-02-27→ Common Stock (69,400 underlying)
Holdings
- 8,129(indirect: By Spouse)
Common Stock
- 829.628(indirect: By 401(k))
Common Stock
- 22,000
Stock Option (right to buy)
Exercise: $83.89From: 2011-02-26Exp: 2018-02-26→ Common Stock (22,000 underlying) - 1,234.091
Deferred Stock
Exercise: $0.00→ Common Stock (1,234.091 underlying) - 40,000
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (40,000 underlying) - 39,220
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (39,220 underlying) - 59,560
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (59,560 underlying)
Footnotes (9)
- [F1]The $91.1 price reported is the weighted average sale price. The sale prices ranged from $91.00 to $91.19 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F2]The $92.42 price reported is the weighted average sale price. The sale prices ranged from $92.39 to $92.51 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- [F4]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2009.
- [F5]This option will vest in full if Praxair, Inc. achieves cumulative fiscal year earnings per share growth of at least 33% over 2007 earnings per share at any time prior to January 1, 2011. If vested, the option may be exercised beginning on the third anniversary of the grant date. If Praxair, Inc. fails to meet the cumulative earnings per share goal, this option will be forfeited.
- [F6]This option vests over three years in three consecutive equal annual installments beginning on February 24, 2010.
- [F7]This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
- [F8]Conversion to Praxair Common Stock is on a 1-for-1 basis.
- [F9]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.
Documents
Issuer
PRAXAIR INC
CIK 0000884905
Entity typeother
Related Parties
1- filerCIK 0001190779
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 7:29 PM ET
- Size
- 24.0 KB